Cell-based therapy for Crohn’s disease: time to consider optimization

Amy Lightner

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

Cell-based therapies for the treatment of perianal Crohn’s disease have well-established safety profiles and improved efficacy compared with conventional therapy. However, stem cells are not a homogeneous product and questions remain before we can optimize clinical trials of these treatments and achieve best patient outcomes.

Original languageEnglish (US)
JournalNature Reviews Gastroenterology and Hepatology
DOIs
StateAccepted/In press - Jan 1 2018

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Cell-based therapy for Crohn’s disease: time to consider optimization'. Together they form a unique fingerprint.

  • Cite this